(Q39018200)

8 September 2017

1 reference

title

The current treatment landscape: candidiasis (English)

1 reference

8 September 2017

1 reference

1

Matteo Bassetti

1 reference

8 September 2017

2

Maddalena Peghin

1 reference

8 September 2017

3

Jean-Francois Timsit

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 November 2016

1 reference

Journal of Antimicrobial Chemotherapy

8 September 2017

published in

1 reference

8 September 2017

volume

71

1 reference

8 September 2017

issue

suppl 2

1 reference

8 September 2017

page(s)

ii13-ii22

1 reference

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Multistate point-prevalence survey of health care-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Variations in organism-specific severe sepsis mortality in the United States: 1999-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Echinocandin resistance: an emerging clinical problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Overview of Fungal Infections--The Italian Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

An Italian consensus for invasive candidiasis management (ITALIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

What's new in antifungals: an update on the in-vitro activity and in-vivo efficacy of new and investigational antifungal agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Systemic antifungal therapy in critically ill patients without invasive fungal infection*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Impact of therapeutic strategies on the prognosis of candidemia in the ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update].

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Septic shock attributed to Candida infection: importance of empiric therapy and source control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Candida biomarkers in patients with candidaemia and bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

A matched-control evaluation of an antifungal bundle in the intensive care unit at a university teaching hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Antifungal stewardship: implementation in a French teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Introduction of an antifungal stewardship programme targeting high-cost antifungals at a tertiary hospital in Cambridge, England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKW392

21 January 2018

Identifiers

DOI

10.1093/JAC/DKW392

1 reference

8 September 2017

1 reference